Pediatric Antibiotic Use Associated with Respiratory Syncytial Virus and Influenza in the United States, 2008-2018 | Effectiveness and Impact of Nirsevimab in Chile During the First Season of a National Immunization Strategy against RSV (NIRSE-CL): A Retrospective Observational Study
Oseltamivir Treatment vs Supportive Care for Seasonal Influenza Requiring Hospitalization In Adults with Influenza Requiring Admission to Hospital | Long-term Outcomes of Patients with Pre-existing Coronary Artery Disease after SARS-CoV-2 Infection
FDA approves new mRNA COVID vaccine MNEXSPIKE from Moderna | Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) | Genome-wide Association Study of Long COVID
Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza | Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants | Clinical Effectiveness of Oral Antiviral Treatment for Non-hospitalized High-risk Patients with COVID-19 During Omicron JN.1 Subvariant Wave: A U.S.-based Propensity-matched Cohort Study
Air and Surface Sampling for Clade Ib Monkeypox Virus in United Kingdom Hospitals, 2024 to 2025 | The Clinical Impact of Prolonged Steroid Therapy in Severe COVID-19 Patients: A Retrospective Cohort Study with Propensity Score Matching | Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19 | Self-reported Health, Neuropsychological Tests and Biomarkers in Fully Recovered COVID-19 Patients vs Patients with Post-COVID Cognitive Symptoms: A Pilot Study
A Phase 3 Safety and Efficacy Study of Baloxavir Marboxil in Children Less Than 1 Year Old With Suspected or Confirmed Influenza | COVID-19 Infection History as a Risk Factor for Early Pregnancy Loss: Results from the Electronic Health Record-based Southeast Texas COVID and Pregnancy Cohort Study | Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial
Live Zoster Vaccination and Cardiovascular Outcomes: A Nationwide, South Korean Study | Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants | Early Effectiveness of the BNT162b2 KP.2 Vaccine against COVID-19 in the U.S. Veterans Affairs Healthcare System
Tocilizumab and IVIG Experience During the Service Follow-up in Patients with Severe COVID-19 Pneumonia | Risk of New-Onset Type 2 Diabetes among Vaccinated Adults after Omicron or Delta Variant SARS-CoV-2 Infection
From May 1 to July 31, 2025, all donations made to PWB will be matched and donated to FIMRC, and no matter how many donations are received, PWB pledges a minimum donation of $10,000 and a total gift of up to $20,000.
Fundraiser Kickoff for the Foundation for International Medical Relief of Children Read More »
Efficacy, Safety, and Immunogenicity of the AS01E-adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over Three Respiratory Syncytial Virus Seasons (AReSVi-006): A Multicentre, Randomized, Observer-blinded, Placebo-Controlled, Phase 3 Trial | Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19
Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.
Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.
Spanish 
English